Person who experienced the adverse event (patient)
| Event ID | CASE | I F COD | FOLL SEQ | IMAGE | EVENT DT | MFR DT | FDA DT | REPT COD | MFR NUM | MFR SNDR | AGE | AGE COD | GNDR COD | E SUB | WT | WT COD | REPT DT | OCCP COD | DEATH DT | TO MFR | CONFID | REPORTER COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 5903217 | 6775191 | I | 5903217-X | 20080929 | 20080930 | EXP | DE-BRISTOL-MYERS SQUIBB COMPANY-14351431 | BRISTOL-MYERS SQUIBB COMPANY | 9 | YR | M | Y | 20080930 | OT | GERMANY |
Drug(s) used by person
| Event ID | DRUG SEQ | ROLE COD | DRUGNAME | VAL VBM | ROUTE | DOSE VBM | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 5903217 | 1010519795 | PS | CYCLOPHOSPHAMIDE | 1 | 2 TIMES | 12142 | |||||
| 5903217 | 1010519796 | SS | BUSULFAN | 2 | INTRAVENOUS | 4 TIMES | |||||
| 5903217 | 1010519797 | SS | CYCLOSPORINE | 1 | STARTED ON DAY 1. DOSE REDUCED TO 70 NG/ML ON DAY +21 | ||||||
| 5903217 | 1010519798 | SS | MELPHALAN | 2 | 1 TIMES |
Indications of drugs used
| Event ID | DRUG SEQ | INDI PT |
|---|---|---|
| 5903217 | 1010519795 | BONE MARROW CONDITIONING REGIMEN |
| 5903217 | 1010519796 | BONE MARROW CONDITIONING REGIMEN |
| 5903217 | 1010519797 | PROPHYLAXIS AGAINST GRAFT VERSUS HOST DISEASE |
| 5903217 | 1010519798 | BONE MARROW CONDITIONING REGIMEN |
Outcome of event
| Event ID | OUTC COD |
|---|---|
| 5903217 | OT |
Reactions reported
| Event ID | PT |
|---|---|
| 5903217 | CYSTITIS HAEMORRHAGIC |
| 5903217 | HUMAN POLYOMAVIRUS INFECTION |
| 5903217 | NEPHRITIS INTERSTITIAL |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| Event ID | DRUG SEQ | START DT | END DT | DUR | DUR COD |
|---|---|---|---|---|---|
| 5903217 | 1010519796 | 4 | DAY |